Altshuler Shaham’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-62
Closed -$4.01K 512
2026
Q1
$4.01K Sell
62
-1
-2% -$70 ﹤0.01% 326
2025
Q4
$4.24K Buy
+63
New +$4.24K ﹤0.01% 292
2025
Q2
Sell
-27,500
Closed -$1.75M 336
2025
Q1
$1.75M Hold
27,500
0.04% 45
2024
Q4
$1.31M Hold
27,500
0.04% 47
2024
Q3
$1.57M Buy
27,500
+500
+2% +$28.7K 0.09% 41
2024
Q2
$1.41M Buy
+27,000
New +$1.18M 0.05% 40
2023
Q1
Sell
-460
Closed -$26.2K 422
2022
Q4
$26.2K Sell
460
-1,068
-70% -$54.7K ﹤0.01% 332
2022
Q3
$60K Buy
1,528
+46
+3% +$2.03K ﹤0.01% 190
2022
Q2
$65K Buy
+1,482
New +$64.1K ﹤0.01% 205
2021
Q2
Sell
-943
Closed -$39K 661
2021
Q1
$39K Buy
943
+44
+5% +$2.01K ﹤0.01% 326
2020
Q4
$38K Sell
899
-28
-3% -$1.01K ﹤0.01% 313
2020
Q3
$24K Sell
927
-1,185
-56% -$33K ﹤0.01% 313
2020
Q2
$57K Buy
+2,112
New +$47.6K ﹤0.01% 188

Other funds holding HALO

Altshuler Shaham's HALO Position: Q2 2026 in Review

Altshuler Shaham sold out of Halozyme (HALO) in Q2 2026, closing a stake of 62 shares — an estimated $4.01K sold.

Altshuler Shaham first reported a position in HALO in Q2 2020 and held it in 13 quarters. The position peaked at $1.75M in Q1 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Altshuler Shaham reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Altshuler Shaham sold 62 Halozyme shares in Q2 2026, an estimated $4.01K.
  • Altshuler Shaham first reported a position in Halozyme in Q2 2020 and held it in 13 quarters.
  • Altshuler Shaham's Halozyme position peaked at $1.75M in Q1 2025.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.